Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -3,6x - -4,0x | -3,8x |
| Selected Fwd EBIT Multiple | 0,6x - 0,7x | 0,6x |
| Fair Value | HK$ 0,12 - HK$ 0,14 | HK$ 0,13 |
| Upside | 14,4% - 39,2% | 26,8% |
| Benchmarks | Ticker | Full Ticker |
| Beijing Succeeder Technology Inc. | 688338 | SHSE:688338 |
| Peijia Medical Limited | 9996 | SEHK:9996 |
| Jiangxi Sanxin Medtec Co.,Ltd. | 300453 | SZSE:300453 |
| Shanghai ZJ Bio-Tech Co., Ltd | 688317 | SHSE:688317 |
| Beijing Bohui Innovation Biotechnology Group Co., Ltd. | 300318 | SZSE:300318 |
| Yestar Healthcare Holdings Company Limited | 2393 | SEHK:2393 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 688338 | 9996 | 300453 | 688317 | 300318 | 2393 | ||
| SHSE:688338 | SEHK:9996 | SZSE:300453 | SHSE:688317 | SZSE:300318 | SEHK:2393 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 11.6% | NM- | 31.1% | NM- | 3.9% | NM- | |
| 3Y CAGR | 19.1% | NM- | 14.9% | NM- | 31.0% | NM- | |
| Latest Twelve Months | 30.9% | 29.8% | 28.3% | 45.2% | 7759.0% | -184.0% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 35.1% | -272.0% | 15.6% | 2.1% | -1.7% | 2.9% | |
| Prior Fiscal Year | 37.0% | -74.1% | 17.0% | -95.2% | -12.5% | 5.9% | |
| Latest Fiscal Year | 43.3% | -37.3% | 18.9% | -78.0% | 5.6% | -6.0% | |
| Latest Twelve Months | 43.3% | -37.3% | 18.9% | -78.0% | 8.1% | -6.0% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 4.53x | 3.71x | 2.55x | 2.83x | 7.19x | 0.20x | |
| EV / LTM EBITDA | 10.2x | -11.8x | 10.2x | -6.5x | 38.3x | -6.5x | |
| EV / LTM EBIT | 10.5x | -9.9x | 13.5x | -3.6x | 88.8x | -3.4x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -9.9x | 10.5x | 88.8x | ||||
| Historical EV / LTM EBIT | -123.9x | 5.5x | 16.7x | ||||
| Selected EV / LTM EBIT | -3.6x | -3.8x | -4.0x | ||||
| (x) LTM EBIT | (144) | (144) | (144) | ||||
| (=) Implied Enterprise Value | 524 | 551 | 579 | ||||
| (-) Non-shareholder Claims * | (270) | (270) | (270) | ||||
| (=) Equity Value | 254 | 282 | 309 | ||||
| (/) Shares Outstanding | 2,331.6 | 2,331.6 | 2,331.6 | ||||
| Implied Value Range | 0.11 | 0.12 | 0.13 | ||||
| FX Rate: CNY/HKD | 0.9 | 0.9 | 0.9 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.12 | 0.13 | 0.14 | 0.10 | |||
| Upside / (Downside) | 14.4% | 26.8% | 39.2% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 688338 | 9996 | 300453 | 688317 | 300318 | 2393 | |
| Enterprise Value | 1,393 | 2,281 | 3,821 | 519 | 6,370 | 492 | |
| (+) Cash & Short Term Investments | 1,253 | 713 | 468 | 2,744 | 118 | 94 | |
| (+) Investments & Other | 0 | 327 | 63 | 0 | 0 | 0 | |
| (-) Debt | (0) | (253) | (237) | (5) | (1,003) | (317) | |
| (-) Other Liabilities | 0 | (17) | (85) | 0 | (992) | (47) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,646 | 3,050 | 4,031 | 3,258 | 4,493 | 222 | |
| (/) Shares Outstanding | 106.1 | 654.6 | 514.1 | 189.8 | 816.9 | 2,331.6 | |
| Implied Stock Price | 24.93 | 4.66 | 7.84 | 17.16 | 5.50 | 0.10 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.93 | 1.00 | 1.00 | 1.00 | 0.93 | |
| Implied Stock Price (Trading Cur) | 24.93 | 4.99 | 7.84 | 17.16 | 5.50 | 0.10 | |
| Trading Currency | CNY | HKD | CNY | CNY | CNY | HKD | |
| FX Rate to Reporting Currency | 1.00 | 0.93 | 1.00 | 1.00 | 1.00 | 0.93 | |